Literature DB >> 26550193

Role of WISP3 siRNA in proliferation, apoptosis and invasion of bladder cancer cells.

Jinmin Zeng1, Yixiang Liao1, Jiajie Zhou1, Guanghua Yang1, Kun Ding1, Xianjue Zhang1.   

Abstract

Bladder cancer (BC) is the most common cancers of the urinary tract worldwide, killing thousands of people a year. WISP3 is a cysteine-rich protein that belongs to the CCN (Cyr61, CTGF, Nov) family of proteins. Increasing evidences have linked abnormal levels of CCN family members to tumorigenic effects. In the present study, we found that WISP3 was overexpressed in BC. Knockdown of WISP3by RNA interference in two BC cell lines (5367 and SCaBER cells) significantly inhibited cell proliferation, which may be mediated by cell cycle arrest in G1 phase. Moreover, silencing of WISP3 also induced cell apoptosis via increasing the expression of caspase 3 and caspase 9. Depletion of WISP3 notably inhibited the invasion of BC cells. Our data suggests that inhibition of WISP3 may be a therapeutic strategy for BC.

Entities:  

Keywords:  Bladder cancer; G1 arrest; WISP3; apoptosis; invasion

Year:  2015        PMID: 26550193      PMCID: PMC4612878     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  19 in total

Review 1.  Focus on bladder cancer.

Authors:  Colin P N Dinney; David J McConkey; Randall E Millikan; Xifeng Wu; Menashe Bar-Eli; Liana Adam; Ashish M Kamat; Arlene O Siefker-Radtke; Tomasz Tuziak; Anita L Sabichi; H Barton Grossman; William F Benedict; Bogdan Czerniak
Journal:  Cancer Cell       Date:  2004-08       Impact factor: 31.743

Review 2.  Apoptosis: controlled demolition at the cellular level.

Authors:  Rebecca C Taylor; Sean P Cullen; Seamus J Martin
Journal:  Nat Rev Mol Cell Biol       Date:  2008-03       Impact factor: 94.444

3.  Differential expression and prognostic implications of the CCN family members WISP-1, WISP-2, and WISP-3 in human breast cancer.

Authors:  Simon R Davies; Gareth Watkins; Robert E Mansel; Wen G Jiang
Journal:  Ann Surg Oncol       Date:  2007-04-04       Impact factor: 5.344

Review 4.  Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer.

Authors:  Cheol Kwak; Ja Hyeon Ku; Jae-Young Park; Eunsik Lee; Sang Eun Lee; Chongwook Lee
Journal:  J Urol       Date:  2004-01       Impact factor: 7.450

Review 5.  The pathology of bladder cancer.

Authors:  Victor E Reuter
Journal:  Urology       Date:  2006-03       Impact factor: 2.649

6.  WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer.

Authors:  Celina G Kleer; Yanhong Zhang; Quintin Pan; Sofia D Merajver
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

Review 7.  Caspases in apoptosis and beyond.

Authors:  J Li; J Yuan
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

Review 8.  CCN6 (WISP3) as a new regulator of the epithelial phenotype in breast cancer.

Authors:  Celina G Kleer; Yanhong Zhang; Sofia D Merajver
Journal:  Cells Tissues Organs       Date:  2007       Impact factor: 2.481

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis.

Authors:  Nathalie Planque; Bernard Perbal
Journal:  Cancer Cell Int       Date:  2003-08-22       Impact factor: 5.722

View more
  5 in total

1.  CCN family of proteins: critical modulators of the tumor cell microenvironment.

Authors:  Herman Yeger; Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2016-08-12       Impact factor: 5.782

2.  A potential prognostic model based on miRNA expression profile in The Cancer Genome Atlas for bladder cancer patients.

Authors:  Yan Liu; Dong Yan Zhu; Hong Jian Xing; Yi Hou; Yan Sun
Journal:  J Biol Res (Thessalon)       Date:  2020-05-19       Impact factor: 1.889

3.  Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling.

Authors:  Hong Gao; Fen-Fen Yin; Dong-Xian Guan; Yu-Xiong Feng; Qian-Wen Zheng; Xiang Wang; Min Zhu; Xue-Li Zhang; Shu-Qun Cheng; Tian-Wei Chen; Hao Jiang; Er-Bin Zhang; Jing-Jing Wang; Qian-Zhi Ni; Yan-Mei Yuan; Feng-Kun Zhang; Ning Ma; Hui-Jun Cao; Yi-Kang Wang; Jing-Jing Li; Dong Xie
Journal:  Cell Prolif       Date:  2019-02-22       Impact factor: 6.831

4.  Long noncoding RNA expression profile in fibroblast-like synoviocytes from patients with rheumatoid arthritis.

Authors:  Yu Zhang; Yu-Zhong Xu; Ning Sun; Jian-Hong Liu; Fang-Fang Chen; Xiao-Long Guan; Ang Li; Fei Wang; Qin-Fei Zhao; Hai-Yong Wang; Shu-Sheng Song; Wei Yu; Jian-Ning Zhao; Xiao-Jun Li
Journal:  Arthritis Res Ther       Date:  2016-10-06       Impact factor: 5.156

5.  The matricellular protein CCN6 (WISP3) decreases Notch1 and suppresses breast cancer initiating cells.

Authors:  Wei Huang; Emily E Martin; Boris Burman; Maria E Gonzalez; Celina G Kleer
Journal:  Oncotarget       Date:  2016-05-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.